These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 21560834)

  • 21. Does reviewing fasting plasma glucose results patterns before glycosylated hemoglobin testing in type-2 diabetic patients lead to better testing decision?
    Intharachuti W; Sriratanaban J
    Diabetes Metab Syndr; 2019; 13(3):2080-2085. PubMed ID: 31235140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of fasting plasma glucose and glycosylated hemoglobin among low income Latinos with poorly controlled type 2 diabetes.
    Kollannoor-Samuel G; Chhabra J; Fernandez ML; Vega-López S; Pérez SS; Damio G; Calle MC; D'Agostino D; Pérez-Escamilla R
    J Immigr Minor Health; 2011 Oct; 13(5):809-17. PubMed ID: 21181446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
    Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
    Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients.
    Kempf K; Röhling M; Niedermeier K; Gärtner B; Martin S
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081574
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycated haemoglobin (HbA
    Bazo-Alvarez JC; Quispe R; Pillay TD; Bernabé-Ortiz A; Smeeth L; Checkley W; Gilman RH; Málaga G; Miranda JJ
    Diabet Med; 2017 Jun; 34(6):804-812. PubMed ID: 28196274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between hemoglobin A 1c and spot glucose measurements in Nigerians with type 2 diabetes mellitus.
    Edo AE; Akhuemokhan K
    Niger J Clin Pract; 2012; 15(1):23-6. PubMed ID: 22437083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the Relationship between Morning Glycemic Variability and Patient Characteristics Using Continuous Glucose Monitoring Data in Patients with Type 2 Diabetes.
    Takeishi S; Mori A; Kawai M; Yoshida Y; Hachiya H; Yumura T; Ito S; Shibuya T; Fushimi N; Ohashi N; Kawai H
    Intern Med; 2017; 56(12):1467-1473. PubMed ID: 28626170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosing type 2 diabetes mellitus: in primary care, fasting plasma glucose and glycosylated haemoglobin do the job].
    Jimeno Mollet J; Molist Brunet N; Franch Nadal J; Morató Griera J; Otzet Gramunt I; Pons Barro P
    Aten Primaria; 2004 Sep; 34(5):222-8. PubMed ID: 15456566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.
    Avignon A; Radauceanu A; Monnier L
    Diabetes Care; 1997 Dec; 20(12):1822-6. PubMed ID: 9405900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of fasting and postprandial glucose to hemoglobin A1c.
    Monnier L; Colette C
    Endocr Pract; 2006; 12 Suppl 1():42-6. PubMed ID: 16627379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults.
    Lee J; Lee YA; Kim JH; Lee SY; Shin CH; Yang SW
    Diabetes Metab J; 2019 Apr; 43(2):174-182. PubMed ID: 30398041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs.
    Ohta A; Kato H; Murayama K; Hashimoto E; Murakami M; Nishine A; Ohshige T; Sada Y; Asai S; Kawata T; Nagai Y; Katabami T; Tanaka Y
    Endocr J; 2014; 61(1):13-8. PubMed ID: 24064478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects.
    Du TT; Yin P; Zhang JH; Zhang D; Shi W; Yu XF
    Clin Exp Pharmacol Physiol; 2013 Feb; 40(2):63-8. PubMed ID: 23198814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.
    Stringer F; DeJongh J; Enya K; Koumura E; Danhof M; Kaku K
    Diabetes Technol Ther; 2015 Mar; 17(3):215-23. PubMed ID: 25531677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The features of postprandial glucose state in type 2 diabetes mellitus].
    Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.